Foghorn Therapeutics Inc. (FHTX) Net Income by Year
Foghorn Therapeutics Inc. reported a net loss of $74.3M in fiscal year 2025. This represents an increase of 14.2% from the prior fiscal year. Over the trailing 12 months, Q3 FY2025 through Q2 FY2026, the same line adds up to a $64.6M net loss. The table below carries 7 fiscal years, from 2019 to 2025, and the quarters Foghorn Therapeutics Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
FHTX Net Income by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.
FHTX Net Income by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What net income means
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.
More Foghorn Therapeutics Inc. financials
Frequently Asked Questions
What was Foghorn Therapeutics Inc.'s net income in fiscal year 2025?
Foghorn Therapeutics Inc. reported a net loss of $74.3M in fiscal year 2025.
How fast is Foghorn Therapeutics Inc.'s net income growing?
Foghorn Therapeutics Inc. (FHTX) net income rose by 14.2% year over year, from -$86.6M to -$74.3M in fiscal year 2025.
What is Foghorn Therapeutics Inc.'s net income over the last twelve months?
Foghorn Therapeutics Inc. (FHTX) reported a $64.6M net loss over the trailing 12 months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.
How has Foghorn Therapeutics Inc.'s net income changed over the years?
Across the 7 fiscal years this page covers, Foghorn Therapeutics Inc. (FHTX) net income went from -$51.1M in fiscal year 2019 to -$74.3M in fiscal year 2025.
What was Foghorn Therapeutics Inc.'s net income in the most recent quarter?
Foghorn Therapeutics Inc. (FHTX) reported -$7.2M in net income in Q2 2026. This represents an increase of 59.9% from the same quarter a year earlier.
What does net income mean on a financial statement?
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Foghorn Therapeutics Inc. (FHTX) reported on that line in every period on record.